Akero Therapeutics Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

Akero Therapeutics is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on developing treatments for serious metabolic diseases with high unmet medical need, including MASH. Its lead product candidate, EFX, is being evaluated in the SYMMETRY study, a 96-week Phase 2b trial in patients with compensated cirrhosis due to MASH (F4 fibrosis), and there are three ongoing Phase 3 trials in pre-cirrhotic MASH or compensated cirrhosis: SYNCHRONY Histology, SYNCHRONY Real-World, and SYNCHRONY Outcomes. The SYNCHRONY program builds on two Phase 2b trials, the HARMONY study in pre-cirrhotic MASH (F2-F3) and the SYMMETRY study in compensated cirrhosis due to MASH (F4). The company has 51 to 200 employees and is located at 601 Gateway Boulevard, Suite 350, South San Francisco, CA 94080. In October 2025, Novo Nordisk announced plans to acquire Akero Therapeutics for about $4.7 billion in cash. Financial data indicate revenue in the range of $25 million to $50 million and total funding of $367 million.

Find Akero Therapeutics employees' phone numbers or email addresses

Akero Therapeutics Global Highlights

Location
Employees

North America
77

Minus sign iconPlus sign icon
  • United States Of America
    77

Europe
7

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    6
  • Romania
    1

Asia
3

Minus sign iconPlus sign icon
  • India
    2
  • Turkey
    1

Akero Therapeutics's Leadership

  • Stylized image of a person
    W. W.
    Cfo And Head Of Corporate Development
    Phone icon
  • Stylized image of a person
    S. G.
    Chief Technical Officer
    Phone icon
  • Stylized image of a person
    T. R.
    Chief Scientific Officer
    Phone icon
  • Stylized image of a person
    D. S.
    Chief Operating Officer
    Phone icon
  • Stylized image of a person
    T. R.
    Chief Scientific Officer
    Phone icon
  • Stylized image of a person
    M. J.
    Vp Drug Substance
    Phone icon
  • Stylized image of a person
    A. C.
    President
    Phone icon
  • Stylized image of a person
    S. E.
    Founder
    Phone icon

Akero Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Engineering
  • Operations
  • Program & Project Management
  • Research
  • Finance
  • Other
  • Biotechnology
  • Business
  • Quality Assurance
  • Legal
  • Accounting

Contact profiles from Akero Therapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    W. W.
    Cfo And Head Of Corporate Development
    Phone icon
    United StatesNew York
    Apr 28, 2026
  • Stylized image of a person
    S. G.
    Chief Technical Officer
    Phone icon
    United StatesNew York
    May 21, 2026
  • Stylized image of a person
    T. R.
    Chief Scientific Officer
    Phone icon
    United StatesMassachusetts
    Apr 28, 2026
  • Stylized image of a person
    A. C.
    President
    Phone icon
    Jan 07, 2026
  • Stylized image of a person
    D. S.
    Chief Operating Officer
    Phone icon
    UNITED KINGDOMEast Sussex
    Oct 31, 2023
  • Stylized image of a person
    S. E.
    Founder
    Phone icon
    UNITED KINGDOMEast Sussex
    May 08, 2026
  • Stylized image of a person
    T. R.
    Chief Scientific Officer
    Phone icon
    Dec 09, 2025
  • Stylized image of a person
    L. L.
    Vice President, Head Of Regulatory Affairs
    Phone icon
    Apr 30, 2026
  • Stylized image of a person
    M. J.
    Vp, Clinical Development
    Phone icon
    United StatesMississippi
    May 19, 2026
  • Stylized image of a person
    M. J.
    Vp Drug Substance
    Phone icon
    United StatesNorth Carolina
    May 11, 2026

Frequently Asked Questions

What is Akero Therapeutics known for?

Minus sign iconPlus sign icon
Akero Therapeutics was founded in 2017 operates in the Biotechnology Research industry. The company's main headquarters is located in 601 Gateway Boulevard Suite 350 South San Francisco, California 94080 United States; you can contact the main corporate office by phone at . Explore Akero Therapeutics's company overview page for more information.

What is Akero Therapeutics's most common email format?

Minus sign iconPlus sign icon
Akero Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Akero Therapeutics email formats with LeadIQ.

How many employees does Akero Therapeutics have currently?

Minus sign iconPlus sign icon
Akero Therapeutics has approximately 74 employees as of June 2026. These team members are located across 3 continents, including North AmericaEuropeAsia.

Who are Akero Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of June 2026, Akero Therapeutics's key employees include:

  • Cfo And Head Of Corporate Development: W. W.
  • Chief Technical Officer: S. G.
  • Chief Scientific Officer: T. R.
  • Chief Operating Officer: D. S.
  • Chief Scientific Officer: T. R.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.